Ratio Revelations: Amicus Therapeutics Inc (FOLD)’s Financial Metrics in the Spotlight

Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Amicus Therapeutics Inc (NASDAQ: FOLD) closed the day trading at $10.28 down -0.96% from the previous closing price of $10.38. In other words, the price has decreased by -$0.96 from its previous closing price. On the day, 3.07 million shares were traded. FOLD stock price reached its highest trading level at $10.615 during the session, while it also had its lowest trading level at $10.215.

Ratios:

For a better understanding of FOLD, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.61 and its Current Ratio is at 3.03. In the meantime, Its Debt-to-Equity ratio is 3.40 whereas as Long-Term Debt/Eq ratio is at 3.34.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on May 30, 2024, initiated with a Overweight rating and assigned the stock a target price of $18.

On May 14, 2024, Guggenheim Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $13.

Morgan Stanley Upgraded its Equal-Weight to Overweight on December 19, 2023, whereas the target price for the stock was revised from $15 to $20.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 05 ’24 when Campbell Bradley L sold 6,100 shares for $10.00 per share. The transaction valued at 61,029 led to the insider holds 886,654 shares of the business.

Campbell Bradley L sold 1,400 shares of FOLD for $14,003 on Jul 01 ’24. The President and CEO now owns 886,654 shares after completing the transaction at $10.00 per share. On Jun 03 ’24, another insider, Campbell Bradley L, who serves as the President and CEO of the company, sold 7,500 shares for $10.00 each. As a result, the insider received 75,000 and left with 886,654 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, FOLD now has a Market Capitalization of 3044925696 and an Enterprise Value of 3249814272. For the stock, the TTM Price-to-Sale (P/S) ratio is 7.19 while its Price-to-Book (P/B) ratio in mrq is 23.29. Its current Enterprise Value per Revenue stands at 7.674 whereas that against EBITDA is -66.302.

Stock Price History:

Over the past 52 weeks, FOLD has reached a high of $14.57, while it has fallen to a 52-week low of $9.02. The 50-Day Moving Average of the stock is 2.95%, while the 200-Day Moving Average is calculated to be -9.64%.

Shares Statistics:

Over the past 3-months, FOLD traded about 2.48M shares per day on average, while over the past 10 days, FOLD traded about 2290624 shares per day. A total of 293.59M shares are outstanding, with a floating share count of 288.09M. Insiders hold about 2.74% of the company’s shares, while institutions hold 107.03% stake in the company. Shares short for FOLD as of 1719532800 were 25841210 with a Short Ratio of 10.41, compared to 1717113600 on 27585364. Therefore, it implies a Short% of Shares Outstanding of 25841210 and a Short% of Float of 8.7799996.

Most Popular